IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Genes and Immunity

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gene.6363726PMID 11294564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HLA-DR and -DQ alleles in Italian patients with melanoma.

  2008cited by this paper
• Metastatic malignant melanoma.

  2003cited by this paper
• Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma.

  2000cited by this paper
• Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma.

  1999cited by this paper
• Regulation of Tumor Growth and Metastasis by Interleukin-10: The Melanoma Experience

  1999cited by this paper
• Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical report

  1998cited by this paper
• Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report.

  1998cited by this paper
• HLA-DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population.

  1998cited by this paper
• An investigation of polymorphism in the interleukin-10 gene promoter.

  1997cited by this paper
• Interleukin‐10 is a growth factor for human melanoma cells and down‐regulates HLA class‐I, HLA class‐II and ICAM‐1 molecules

  1997cited by this paper
• Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: an analysis of California Cancer Registry data, 1988-93

  1997cited by this paper
• Increased interleukin-10 serum levels in patients with solid tumours.

  1996cited by this paper
• The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma.

  1996cited by this paper
• Malignant melanoma: relationship of the human leukocyte antigen Class II gene DQB1*0301 to disease recurrence in American Joint Committee on Cancer Stage I or II

  1996cited by this paper
• Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism

  1996cited by this paper
• Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer.

  1996cited by this paper
• Interleukin‐10 production in malignant melanoma: Preferential detection of IL‐10‐secreting tumor cells in metastatic lesions

  1996cited by this paper
• Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma.

  1995cited by this paper
• Production of IL‐10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma

  1994cited by this paper
• Analysis of antigens recognized on human melanoma cells by A2‐restricted cytolytic t lymphocytes (CTL)

  1993cited by this paper
• Cutaneous malignant melanoma, Scotland, 1979-89

  1992cited by this paper
• HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

  1992cited by this paper
• Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.

  1992cited by this paper
• IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

  1991cited by this paper
• Model predicting survival in stage I melanoma based on tumor progression.

  1989cited by this paper
• Malignant melanoma in Scotland 1979-1983.

  1985cited by this paper
• The manual for the staging of cancer.

  1977cited by this paper

• Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology

  2024cites this paper
• The Immunogenetics of Melanoma.

  2022cites this paper
• Potency analysis of cellular therapies: the role of molecular assays

  2021cites this paper
• Mesenchymal-Stromal Cell-like Melanoma-Associated Fibroblasts Increase IL-10 Production by Macrophages in a Cyclooxygenase/Indoleamine 2,3-Dioxygenase-Dependent Manner

  2021cites this paper
• Multivariate data analysis in cell gene therapy manufacturing.

  2020cites this paper
• Associations Between IL-10 Polymorphisms and Susceptibility to Melanoma, Basal Cell Carcinoma, and Squamous Cell Carcinoma: A Meta-Analysis

  2018influential citation
• Chapter 113 – Human Leukocyte Antigen and Human Neutrophil Antigen Systems

  2018cites this paper
• Association of interleukin-10 polymorphisms and haplotypes with the risk of breast cancer in northern China

  2017cites this paper
• Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP

  2017cites this paper
• Interleukin-10 −592C/A, but not −1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case–control study

  2017cites this paper
• Genetic variations of IL‐10: Identification of novel variations and evaluation of the impact of the SNPs/haplotype in the promoter region with the progression of Oral Squamous Cell Carcinoma in Indian population

  2017cites this paper
• The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs’ activation and function

  2017cites this paper
• Association of SNPs/haplotypes in promoter of TNF A and IL-10 gene together with life style factors in prostate cancer progression in Indian population

  2017cites this paper
• Synthetic analysis of associations between IL-10 polymorphisms and skin cancer risk

  2017cites this paper
• Inflammatory breast cancer: High incidence of GCC haplotypes (−1082A/G, −819T/C, and −592A/C) in the interleukin-10 gene promoter correlates with over-expression of interleukin-10 in patients’ carcinoma tissues

  2017cites this paper
• A pooled analysis of the IL-10-1082 A/G polymorphism and the nasopharyngeal carcinoma susceptibility

  2016cites this paper
• Germline determinants of clinical outcome of cutaneous melanoma

  2016influential citation
• [Th9 cells: a new population of helper T cells].

  2016cites this paper
• The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis

  2016cites this paper
• Association of interleukin-10 (A1082G) gene polymorphism with oral squamous cell carcinoma in north Indian population

  2016cites this paper
• Clinical significance of IL-2 and IL-10 gene polymorphisms and serum levels in patients with basal-cell carcinoma.

  2016cites this paper
• IL10 Variant g.5311A Is Associated with Visceral Leishmaniasis in Indian Population

  2015cites this paper
• Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma

  2015cites this paper
• Pathologic patterns of interleukin 10 expression – A review

  2015cites this paper
• Novel mutations in IL-10 promoter region -377 (C>T), -150 (C>A) and their association with psoriasis in the saudi population.

  2015cites this paper
• Association Between Interleukin-10-3575T>A (rs1800890) Polymorphism and Cancer Risk

  2015cites this paper
• Potency Analysis of Cellular Therapies

  2015cites this paper
• The Differential Contribution of Behavior and Biology to Breslow Thickness and Melanoma Survival in Males Compared to Females

  2015cites this paper
• The association of IL-8-251T/A polymorphism with complicated malaria in Karbi Anglong district of Assam.

  2014cites this paper
• -592 and -1082 interleukin-10 polymorphisms in pulmonary tuberculosis with type 2 diabetes.

  2013cites this paper
• Gene Variants in Angiogenesis and Lymphangiogenesis and Cutaneous Melanoma Progression

  2013cites this paper
• Document heading doi :-592 and-1082 interleukin-10 polymorphisms in pulmonary tuberculosis with type 2 diabetes

  2013cites this paper
• The Interleukin 10 −819C/T Polymorphism and Cancer Risk: A HuGE Review and Meta-Analysis of 73 Studies Including 15,942 Cases and 22,336 Controls

  2013cites this paper
• Melanoma risk loci as determinants of melanoma recurrence and survival

  2013cites this paper
• The Interleukin-10 Promoter Polymorphism rs1800872 (-592C>A), Contributes to Cancer Susceptibility: Meta-Analysis of 16 785 Cases and 19 713 Controls

  2013cites this paper
• Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer

  2013cites this paper
• Interleukin-10-819C>T polymorphism contributed to cancer risk: evidence from 29 studies.

  2013cites this paper
• Germline melanoma susceptibility and prognostic genes: a review of the literature.

  2012cites this paper
• Is interleukin-10 gene polymorphism a predictive marker in HCV infection?

  2012cites this paper
• ASSOCIATION OF TUMOR NECROSIS FACTOR &agr;, INTERLEUKIN 6, AND INTERLEUKIN 10 PROMOTER POLYMORPHISM WITH PROLIFERATIVE DIABETIC RETINOPATHY IN TYPE 2 DIABETIC SUBJECTS

  2012cites this paper
• Global Transcriptional Analysis for Biomarker Discovery and Validation in Cellular Therapies

  2012cites this paper
• Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.

  2011cites this paper
• IL-10 polymorphisms and prostate cancer risk: a meta-analysis

  2011cites this paper
• Polymorphisms in Inflammation-Related Genes and Risk of Smoking-associated Lung Cancer and Chronic Obstructive Pulmonary Disease

  2011cites this paper
• Polymorphism and expression of IL-10 in serum and ascites from patients with advanced ovarian cancer

  2011cites this paper
• Association of interferon-gamma, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms with occurrence and severity of Eales' disease.

  2011cites this paper
• Quality assessment of cellular therapies: the emerging role of molecular assays

  2010cites this paper
• Angiogenesis-associated sequence variants relative to breast cancer recurrence and survival

  2010cites this paper
• Association of longevity with IL‐10 −1082 G/A and TNF‐α−308 G/A polymorphisms

  2010cites this paper
• Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk

  2010cites this paper
• Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations

  2010cites this paper
• Genetic variants in inflammation pathway genes and asthma in glioma susceptibility.

  2010cites this paper
• Molecular Signatures Linked With Aggressive Behavior in Basal Cell Carcinoma: A Report of 6 Cases

  2010cites this paper
• Cox-2 and IL-10 Polymorphisms and Association with Squamous Cell Carcinoma of The Head and Neck in a Korean Sample

  2010cites this paper
• Cytokine polymorphism in noninfectious uveitis.

  2010cites this paper
• Angiogenesis-associated sequence variants relative to breast

  2010cites this paper
• Global Transcriptional Analysis for Biomarker Discovery and Validation in Cancer and Hematological Malignancy Biologic Therapies

  2010cites this paper
• Polymorphisms in heat shock protein receptors

  2009cites this paper
• The Prostate InteractionAmongVariantVascular Endothelial Growth Factor ( VEGF ) and Its Receptor in Relationto ProstateCancerRisk Tiva

  2009cites this paper
• Associations of Cytokine Polymorphisms with Immunosenescence

  2009cites this paper
• Identification of modifier genes for cutaneous malignant melanoma in melanoma‐prone families with and without CDKN2A mutations

  2009cites this paper
• Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case–control study

  2009cites this paper
• Immunomics of Immune Rejection

  2009cites this paper
• Interlukin-10, Interferon-γ and Tumor Necrosis Factor-α Genes Variation in Prostate Cancer and Benign Prostatic Hyperplasia

  2009cites this paper
• Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins

  2009cites this paper
• Association between a common IL10 distal promoter haplotype and IgE production in individuals with atopic dermatitis

  2009cites this paper
• A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.

  2009cites this paper
• Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma

  2008cites this paper
• Genetic variation in interleukin-10 gene and risk of oral cancer.

  2008cites this paper
• Polimorfismos de genes de citocinas e do gene MICA em pacientes com neoplasia infra-epitelial cervical /

  2008cites this paper
• Interleukin-8 promoter polymorphism −251A/T is a risk factor for age-related macular degeneration

  2008cites this paper
• The effects of autologous platelet gel on inflammatory cytokine response in human peripheral blood mononuclear cells

  2008cites this paper
• Cytokine-Based Therapy for Cancer

  2008cites this paper
• The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma.

  2008cites this paper
• Cytokine single nucleotide polymorphisms in Iranian populations.

  2008cites this paper
• Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.

  2007cites this paper
• Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients

  2007cites this paper
• Potency analysis of cellular therapies: the emerging role of molecular assays

  2007cites this paper
• Cytokine gene polymorphisms, cancer susceptibility, and prognosis.

  2007cites this paper
• The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma.

  2007cites this paper
• Involvement of Interleukin‐10 Promoter Polymorphisms in Nonmelanoma Skin Cancers—A Case Study in Non‐Caucasian Skin Cancer Patients †

  2007cites this paper
• The interleukin-10-1082 'A' allele and abdominal aortic aneurysms.

  2007cites this paper
• CD40-induced countercurrent conduits for tumor escape or elimination?

  2007cites this paper
• Immunogenetics of Aging

  2007cites this paper
• Chapter 10 – Human Leukocyte and Granulocyte Antigens and Antibodies: The HLA and HNA Systems

  2007cites this paper
• Th1 and Th2 cytokine gene polymorphisms in two indigenous ethnic groups in Iran

  2006cites this paper
• Cytokine Gene Polymorphisms , Cancer Susceptibility , and Prognosis 1 – 3

  2006cites this paper
• The IL19 Subfamily of Cytokines

  2006cites this paper
• Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population

  2006cites this paper
• The genetics of melanoma.

  2006cites this paper
• The effect of genetic diversity on angiogenesis.

  2006cites this paper
• Interleukin‐10 and the immune response against cancer: a counterpoint

  2005cites this paper
• Microarrays: Gene expression profiling approaches for the monitoring of anti-cancer immune responses

  2005cites this paper
• Interleukin-10 -1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China.

  2005cites this paper
• An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma.

  2005cites this paper
• ICAM‐1 polymorphisms and development of cutaneous malignant melanoma

  2005cites this paper
• The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.

  2005cites this paper
• Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.

  2005cites this paper
• Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease

  2005cites this paper
• Interleukin‐10 haplotype associated with total serum IgE in atopic dermatitis patients

  2005cites this paper